drugset / Trial / NCT05431673

Efficacy Of Doxycycline & Versus Rifampin In Treatment Of Rhinoscleroma

NCT05431673 ↗

Phase 1 Unknown 45 enrolled Assiut University
RandomizedParallel-groupSingle-blindTreatment

Summary

The study is conducted To evaluate the Efficacy of Doxycycline (alone and in combination with Ciprofloxacin) as an alternative to the regular regimen in treating rhinoscleroma, especially for cases with contraindication to the use of one or more of the regularly used drugs.

Timeline

Start
2022-08-21
Primary completion
2023-06-30
Completion
2023-07-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ciprofloxacin Small molecule 250 mg —
Comparator Doxycycline Small molecule 100 mg —
Comparator Rifampicin Small molecule 600 mg —

Indications